|
What Is Cystic Fibrosis ?>
Cystic fibrosis (CF) is a chronic, progressive, and frequently
fatal genetic (inherited) disease of the body's mucus glands. CF
primarily affects the respiratory and digestive systems in children
and young adults. The sweat glands and the reproductive system are
also usually involved.
On the average, individuals with CF have a lifespan of approximately
30 years. CF-like disease has been known for over two centuries.
The name, cystic fibrosis of the pancreas, was first applied to
the disease in 1938.
How Common Is CF? According to the
data collected by the Cystic Fibrosis Foundation, there are about
30,000 Americans, 3,000 Canadians, and 20,000 Europeans with CF.
The disease occurs mostly in whites whose ancestors came from northern
Europe, although it affects all races and ethnic groups. Accordingly,
it is less common in African Americans, Native Americans, and Asian
Americans. Approximately 2,500 babies are born with CF each year
in the United States. Also, about 1 in every 20 Americans is an
unaffected carrier of an abnormal "CF gene." These 12 million people
are usually unaware that they are carriers.
What Are the Signs and Symptoms of CF? CF does not follow the same
pattern in all patients but affects different people in different
ways and to varying degrees. However, the basic problem is the same-an
abnormality in the glands, which produce or secrete sweat and mucus.
Sweat cools the body; mucus lubricates the respiratory, digestive,
and reproductive systems, and prevents tissues from drying out,
protecting them from infection.
People with CF lose excessive amounts of salt when they sweat.
This can upset the balance of minerals in the blood, which may cause
abnormal heart rhythms. Going into shock is also a risk. Mucus in
CF patients is very thick and accumulates in the intestines and
lungs. The result is malnutrition, poor growth, frequent respiratory
infections, breathing difficulties, and eventually permanent lung
damage.
Lung disease is the usual cause of death
in most patients. CF can cause various other medical problems.
These include sinusitis (inflammation of the nasal sinuses, which
are cavities in the skull behind, above, and on both sides of the
nose), nasal polyps (fleshy growths inside the nose), clubbing (rounding
and enlargement of fingers and toes), pneumothorax (rupture of lung
tissue and trapping of air between the lung and the chest wall),
hemoptysis (coughing of blood), cor pulmonale (enlargement of the
right side of the heart), abdominal pain and discomfort, gassiness
(too much gas in the intestine), and rectal prolapse (protrusion
of the rectum through the anus). Liver disease, diabetes, inflammation
of the pancreas, and gallstones also occur in some people with CF.
When Should You Suspect That a Child May
Have CF? CF symptoms vary from child to child. A baby born
with the CF genes usually has symptoms during its first year. Sometimes,
however, signs of the disease may not show up until adolescence
or even later. Infants or young children should be tested for CF
if they have persistent diarrhea, bulky foul-smelling and greasy
stools, frequent wheezing or pneumonia, a chronic cough with thick
mucus, salty-tasting skin, or poor growth. CF should be suspected
in babies born with an intestinal blockage called meconium ileus.
How Is CF Diagnosed? The most common
test for CF is called the sweat test. It measures the amount of
salt (sodium chloride) in the sweat. In this test, an area of the
skin (usually the forearm) is made to sweat by using a chemical
called pilocarpine and applying a mild electric current. To collect
the sweat, the area is covered with a gauze pad or filter paper
and wrapped in plastic. After 30 to 40 minutes, the plastic is removed,
and the sweat collected in the pad or paper is analyzed. Higher
than normal amounts of sodium and chloride suggest that the person
has cystic fibrosis.
CYSTIC FIBROSIS GENE The presence of
two mutant genes (g) is needed for CF to appear. Each parent carries
one defective gene (g) and one normal gene (G). The single normal
gene is sufficient for normal function of the mucus glands, and
the parents are therefore CF-free. Each child has a 25 percent risk
of inheriting two defective genes and getting CF, a 25 percent chance
of inheriting two normal genes, and a 50 percent chance of being
an unaffected carrier like the parents.
The sweat test may not work well in newborns because they do not
produce enough sweat. In that case, another type of test, such as
the immunoreactive trypsinogen test (IRT), may be used. In the IRT
test, blood drawn 2 to 3 days after birth is analyzed for a specific
protein called trypsinogen. Positive IRT tests must be confirmed
by sweat and other tests.
Also, a small percentage of people with CF have normal sweat chloride
levels. They can only be diagnosed by chemical tests for the presence
of the mutated gene. Some of the other tests that can assist in
the diagnosis of CF are chest x-rays, lung function tests, and sputum
(phlegm) cultures. Stool examinations can help identify the digestive
abnormalities that are typical of CF.
What Makes CF a Genetic Disease? Genes
are the basic units of heredity. They are located on structures
within the cell nucleus called chromosomes. The function of most
genes is to instruct the cells to make particular proteins, most
of which have important life-sustaining roles. Every human being
has 46 chromosomes, 23 inherited from each parent. Because each
of the 23 pairs of chromosomes contains a complete set of genes,
every individual has two sets (one from each parent) of genes for
each function. In some individuals, the basic building blocks of
a gene (called base pairs) are altered (mutated). A mutation can
cause the body to make a defective protein or no protein at all.
The result is a loss of some essential biological function and that
leads to disease. Children may inherit altered genes from one or
both parents. Diseases such as CF that are caused by inherited genes
are called genetic diseases. In CF, each parent carries one abnormal
CF gene and one normal CF gene but shows no evidence of the disease
because the normal CF gene dominates or "recesses" the abnormal
CF gene. To have CF, a child must inherit two abnormal genes-one
from each parent. The recessive CF gene can occur in both boys and
girls because it is located on non-sex-linked chromosomes called
autosomal chromosomes. CF is therefore called an autosomal recessive
genetic disease. The inheritance patterns for the CF gene are shown
in the accompanying diagram. Each child, whether male or female,
has a 25 percent risk of inheriting a defective gene from each parent
and of having CF. A child born to two CF patients (an unlikely event)
would be at a 100 percent risk of developing CF.
How Does the Gene Mutation Cause CF?
The CF gene was identified in 1989. Since then, a great deal has
been learned about this gene and its protein product. The biochemical
abnormality in CF results from a mutation in a gene that produces
a protein responsible for the movement through the cell membranes
of chloride ions (a component of sodium chloride, or common table
salt). The protein is called CFTR-cystic fibrosis transmembrane
regulator. CFTR is present in cells that line the passageways of
the lungs, pancreas, colon, and genitourinary tract. When this protein
is abnormal, two of the hallmarks of CF result- blockage of the
movement of chloride ions and water in the lung and other cells
and secretion of abnormal mucus. The mutation involved in CF causes
the deletion of three of the base pairs in the gene. This in turn,
causes a loss in the CFTR protein of an amino acid (the building
blocks of proteins). Because phenylalanine is located in position
508 of the protein chain, this mutant protein is called deltaF508
CFTR. However, deltaF508 CFTR accounts for only 70-80 percent of
all CF cases. Various other mutations-over 400 at the last count-seem
to be responsible for the remaining CF cases. Differences in disease
patterns seen in individuals and families probably result from the
combined effects of the particular mutation and various, but still
unknown, factors in the CF patient and his or her environment.
|